Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
15000 participants
OBSERVATIONAL
2022-06-22
2042-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Metabolomics Study of Polycystic Ovary Syndrome
NCT03618342
Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)
NCT00606671
PCOS Indirect and Intangible Economic Burden
NCT05903404
Novel Subtypes of Polycystic Ovary Syndrome
NCT06124391
Living With Polycystic Ovary Syndrome
NCT04777461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Target Population
The target population includes individuals diagnosed with PCOS by a healthcare provider, self-diagnosed with PCOS, or who are exhibiting PCOS Symptoms and willing to sign the consent.
No interventions assigned to this group
Control Population
The control population includes people born biologically female who have not been diagnosed with PCOS and who also do not have symptoms of PCOS.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to sign the consent form
* Able to understand the registry surveys or what is being asked
Exclusion Criteria
* Unwilling to sign the consent form
12 Years
80 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PCOS Challenge: The National Polycystic Ovary Syndrome Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sasha Ottey, MHA, MT (ASCP)
Role: PRINCIPAL_INVESTIGATOR
PCOS Challenge: The National Polycystic Ovary Syndrome Association
Ricardo Azziz, MD, MPH, MBA
Role: PRINCIPAL_INVESTIGATOR
The University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PCOS Challenge: The National Polycystic Ovary Syndrome Association
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCOSC001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.